Dr. Steven Dubinett is Associate Vice Chancellor for Research and Director of the JCCC Lung Cancer Research Program. He has extensive experience in translational investigation, academic administration, mentorship and peer review. He is Chief, Division of Pulmonary and Critical Care Medicine and jointly appointed as Professor in the Departments of Medicine, Pathology and Laboratory Medicine, and Molecular and Medical Pharmacology. He has served on national advisory panels and committees including the NCI’s Translational Research Working Group. He has experience directing large, multidisciplinary research teams funded by the NCI SPORE program, the Early Detection Research Network and the Department of Defense. He has served as a permanent member of three different NIH study sections and numerous Special Emphasis Panels. He has been consistently funded by peer-reviewed federal resources for translational research in lung cancer for more than 20 years. He served as a member of the FDA Cellular, Tissue and Gene Therapies Advisory Committee and on several editorial boards including Clinical and Translational Science. He is an Associate Editor in Chief of the American Journal of Translational Research.